Sunday, March 9 2014 8:35 PM EDT2014-03-10 00:35:58 GMT
LOUISVILLE, Ky. (WDRB) --- Louisville head football coach Bobby Petrino held a news conference before the Louisville-UConn men's basketball game Saturday to preview the start of spring football. The CardinalsMore >>
Petrino talked quarterback competition and the arrest of an incoming freshman, among other topics...More >>
Follow the WDRB Newsroom, Reporters and Anchors.More >>
Tweets from the WDRB Newsroom, Reporters and Anchors.More >>
LOUISVILLE, Ky. (WDRB) -- The University of Louisville is celebrating a move that will help its research program to save lives around the world.
University officials announced Wednesday that renowned U of L researcher Suzanne Ildstad and her company Regenerex have entered into an agreement with pharmaceutical giant Novartis.
It's hoped the move will enable stem-cell technology developed by Ildstad and her team to prevent rejection of kidney transplants to be made available worldwide much sooner.
"We needed to commercialize it to make it widely available. And, we're really optimistic that through the collaboration with Novartis we'll be able to do that. And, it's just fantastic to be planning to have a worldwide initiative and move into a pivotal trial through the kidneys and possibly the metabolics in very short order," Ildstad told reporters.
It's also hoped Novartis will use the U of L research to develop treatments for other diseases.